387 reports of this reaction
2.5% of all FEXOFENADINE HCL reports
#6 most reported adverse reaction
DIZZINESS is the #6 most commonly reported adverse reaction for FEXOFENADINE HCL, manufactured by CVS Pharmacy. There are 387 FDA adverse event reports linking FEXOFENADINE HCL to DIZZINESS. This represents approximately 2.5% of all 15,768 adverse event reports for this drug.
Patients taking FEXOFENADINE HCL who experience dizziness should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DIZZINESS is a less commonly reported adverse event for FEXOFENADINE HCL, but still significant enough to appear in the safety profile.
In addition to dizziness, the following adverse reactions have been reported for FEXOFENADINE HCL:
The following drugs have also been linked to dizziness in FDA adverse event reports:
DIZZINESS has been reported as an adverse event in 387 FDA reports for FEXOFENADINE HCL. This does not prove causation, but indicates an association observed in post-market surveillance data.
DIZZINESS accounts for approximately 2.5% of all adverse event reports for FEXOFENADINE HCL, making it a notable side effect.
If you experience dizziness while taking FEXOFENADINE HCL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.